Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 0.00 |
| SG&A Expenses | 1.30M | 1.46M | 1.58M | 1.46M | 1.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.38M | 3.59M | 4.21M | 3.67M | 2.93M |
| Operating Income | -3.38M | -3.59M | -4.21M | -3.67M | -2.93M |
| Income Before Tax | -3.34M | -3.49M | -4.08M | -3.53M | -2.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.34M | -3.49M | -4.08M | -3.53M | -2.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.34M | -3.49M | -4.08M | -3.53M | -2.97M |
| EBIT | -3.38M | -3.59M | -4.21M | -3.67M | -2.93M |
| EBITDA | -3.38M | -3.59M | -4.21M | -3.67M | -2.93M |
| EPS Basic | -1.55 | -2.32 | -3.32 | -4.59 | -4.81 |
| Normalized Basic EPS | -0.97 | -1.45 | -2.08 | -2.87 | -2.78 |
| EPS Diluted | -1.55 | -2.32 | -3.32 | -4.59 | -4.81 |
| Normalized Diluted EPS | -0.97 | -1.45 | -2.08 | -2.87 | -2.78 |
| Average Basic Shares Outstanding | 2.16M | 1.50M | 1.23M | 768.10K | 617.80K |
| Average Diluted Shares Outstanding | 2.16M | 1.50M | 1.23M | 768.10K | 617.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |